Japanese Government Procurement

Sapporo CityA Aflibercept (Genetical Recombination) kit for IVT Injection 40 mg/mL set of 1 kit: approx. 1350 sets B Daratumumab (Genetical Recombination) Vorhyaluronidase Alfa (Genetical Recombination) Combination SC injection set of 1 vial: approx. 290 sets C Pembrolizumab (Genetical Recombination) IV Infu...

Japanese

Publishing date Jan 31, 2023
Procurement entity Sapporo City（Hokkaido）
Classification
0004 Medical & Pharmaceutical Products
Summary of notice Summary
(1) Nature and the quantity of the products to be
procured
A Aflibercept (Genetical Recombination) kit
for IVT Injection 40 mg/mL set of 1 kit:
approx. 1350 sets
B Daratumumab (Genetical Recombination)
Vorhyaluronidase Alfa (Genetical
Recombination) Combination SC injection set
of 1 vial: approx. 290 sets
C Pembrolizumab (Genetical Recombination) IV
Infusion 100 mg set of 1 vial: approx. 380 sets
D Nivolumab (Genetical Recombination) IV
Infusion 240 mg set of 1 vial: approx. 220
sets
E Lenalidomide Hydrate Capsules 5 mg set of
40 capsules: approx. 230 sets
F Ravulizumab (Genetical Recombination) IV
Infusion 300 mg set of 1 vial: approx. 80 sets
G Durvalumab (GeneticalRecombination) IV
Infusion 500 mg set of 1 vial: approx. 140 sets
H Avelumab (Genetical Recombination) IV
Infusion 200 mg set of 1 vial: approx. 240
sets
I Ranibizumab (Genetical Recombination) kit
for IVT Injection 10 mg/mL set of 1 kit:
approx. 330 sets
J Remdesivir lyophilized preparations for IV
100 mg set of 1 vial: approx. 550 sets
K Palivizumab (Genetical Recombination)
Solution for IM Administration 100 mg set of
1 vial: approx. 310 sets
(2) Time limit for tender: 17:00 on March 13
(Mon.), 2023
(3) Contact point for the notice: Management &
Planning Section, Management Department,
Management Office, Hospital Bureau, Sapporo
Municipal Government, Kita 11-jo Nishi 13-
chome, Chuo-ku, Sapporo 060-8604, Japan.
TEL 011-726-2211